These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24286415)

  • 41. Outcomes of an enhanced surveillance program for carbapenem-resistant Enterobacteriaceae.
    Fitzpatrick M; Zembower T; Malczynski M; Qi C; Bolon MK
    Infect Control Hosp Epidemiol; 2014 Apr; 35(4):419-22. PubMed ID: 24602948
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Carbapenem-resistant Enterobacteriaceae: a call for cultural change.
    Palmore TN; Henderson DK
    Ann Intern Med; 2014 Apr; 160(8):567-9. PubMed ID: 24733200
    [No Abstract]   [Full Text] [Related]  

  • 43. Carbapenem-resistant enterobacteriaceae: an emerging problem in children.
    Logan LK
    Clin Infect Dis; 2012 Sep; 55(6):852-9. PubMed ID: 22700827
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Carbapenem-resistant Enterobacteriaceae and endoscopy: An evolving threat.
    O'Horo JC; Farrell A; Sohail MR; Safdar N
    Am J Infect Control; 2016 Sep; 44(9):1032-6. PubMed ID: 27179395
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carbapenem-resistant Enterobacteriaceae and the correlation between carbapenem and fluoroquinolone usage and resistance in the US military health system.
    Lesho EP; Clifford RJ; Chukwuma U; Kwak YI; Maneval M; Neumann C; Xie S; Nielsen LE; Julius MD; McGann P; Waterman PE
    Diagn Microbiol Infect Dis; 2015 Feb; 81(2):119-25. PubMed ID: 25497458
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae.
    Patel N; Harrington S; Dihmess A; Woo B; Masoud R; Martis P; Fiorenza M; Graffunder E; Evans A; McNutt LA; Lodise TP
    J Antimicrob Chemother; 2011 Jul; 66(7):1600-8. PubMed ID: 21508008
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical impact of infections with carbapenem-resistant enterobacteriaceae in liver transplant recipients].
    Lübbert C; Hau HM; Rodloff A; Mössner J; Mischnik A; Bercker S; Bartels M; Kaisers UX
    Z Gastroenterol; 2015 Nov; 53(11):1276-87. PubMed ID: 26562402
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Novel Risk Factor Associated With Colonization by Carbapenemase-Producing Enterobacteriaceae: Use of Proton Pump Inhibitors in Addition to Antimicrobial Treatment.
    Cheng VC; Chen JH; So SY; Wong SC; Chau PH; Wong LM; Ching RH; Ng MM; Lee WM; Hung IF; Ho PL; Yuen KY
    Infect Control Hosp Epidemiol; 2016 Dec; 37(12):1418-1425. PubMed ID: 27619653
    [TBL] [Abstract][Full Text] [Related]  

  • 49. How to stem the tide of carbapenemase-producing enterobacteriaceae?: proactive versus reactive strategies.
    Bilavsky E; Schwaber MJ; Carmeli Y
    Curr Opin Infect Dis; 2010 Aug; 23(4):327-31. PubMed ID: 20581673
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Novel Protocol Obviates Endoscope Sampling for Carbapenem-Resistant Enterobacteriaceae: Experience of a Center with a Prior Outbreak.
    Smith ZL; Dua A; Saeian K; Ledeboer NA; Graham MB; Aburajab M; Ballard DD; Khan AH; Dua KS
    Dig Dis Sci; 2017 Nov; 62(11):3100-3109. PubMed ID: 28681083
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Challenges in the management of infections due to carbapenem-resistant Enterobacteriaceae.
    Drekonja DM; Beekmann SE; Elliott S; Mukundan D; Polenakovik H; Rosenthal ME; Tamma PD; Polgreen PM; Weissman SJ
    Infect Control Hosp Epidemiol; 2014 Apr; 35(4):437-9. PubMed ID: 24602953
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The outcome of treating ESBL infections with carbapenems vs. non carbapenem antimicrobials.
    Trivedi M; Patel V; Soman R; Rodriguez C; Singhal T
    J Assoc Physicians India; 2012 Aug; 60():28-30. PubMed ID: 23405518
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies.
    Satlin MJ; Jenkins SG; Walsh TJ
    Clin Infect Dis; 2014 May; 58(9):1274-83. PubMed ID: 24463280
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study.
    McConville TH; Sullivan SB; Gomez-Simmonds A; Whittier S; Uhlemann AC
    PLoS One; 2017; 12(10):e0186195. PubMed ID: 29023567
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of antimicrobial stewardship in curbing carbapenem resistance.
    Bogan C; Marchaim D
    Future Microbiol; 2013 Aug; 8(8):979-91. PubMed ID: 23902145
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epidemiology and successful containment of a carbapenem-resistant Enterobacteriaceae outbreak in a Southern Italian Transplant Institute.
    Mularoni A; Martucci G; Douradinha B; Campanella O; Hazen B; Medaglia A; Arena G; Gruttadauria S; Tuzzolino F; Arcadipane A; Gioè S; Luca A; Conaldi PG; Grossi P; Gridelli B
    Transpl Infect Dis; 2019 Aug; 21(4):e13119. PubMed ID: 31112353
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A matrix management of prevention and control for carbapenem-resistant Enterobacteriaceae in an urban compact medical union.
    Yang M; Huang Y; Li Q; Zhao H; Liu X; Gao S; Zhou X; Chen Y
    Indian J Med Microbiol; 2023; 43():30-35. PubMed ID: 36357265
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Healthcare Antibiotic Resistance Prevalence - DC (HARP-DC): A Regional Prevalence Assessment of Carbapenem-Resistant Enterobacteriaceae (CRE) in Healthcare Facilities in Washington, District of Columbia.
    Reuben J; Donegan N; Wortmann G; DeBiasi R; Song X; Kumar P; McFadden M; Clagon S; Mirdamadi J; White D; Harris JE; Browne A; Hooker J; Yochelson M; Walker M; Little G; Jernigan G; Hansen K; Dockery B; Sinatro B; Blaylock M; Harmon K; Iyengar P; Wagner T; Nelson JA;
    Infect Control Hosp Epidemiol; 2017 Aug; 38(8):921-929. PubMed ID: 28615088
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Demographic and infection characteristics of patients with carbapenem-resistant Enterobacteriaceae in a community hospital: Development of a bedside clinical score for risk assessment.
    Miller BM; Johnson SW
    Am J Infect Control; 2016 Feb; 44(2):134-7. PubMed ID: 26492818
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Urinary Tract Infections and Surgical Site Infections due to Carbapenem-Resistant Enterobacteriaceae in Renal Transplant.
    Rodrigues Dos Santos BG; Amaral ES; Fernandes PF; Oliveira CM; Rodrigues JL; Perdigão Neto LV; Girão ES
    Transplant Proc; 2016; 48(6):2050-5. PubMed ID: 27569943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.